Significance of Preoperative Chemotherapy and Chemoradiotherapy in Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer
Treatment with multiple regimens may improve the prognosis of patients with LAPC or BRPC. The addition of chemoradiotherapy as a treatment modality may have a positive impact on prognosis.
Authors
- Satoshi Kobayashi (ORCID: https://orcid.org/0000-0002-7760-0771)
- Takashi Ohshima (ORCID: https://orcid.org/0000-0001-9817-6984)
- Soichiro Morinaga
- Naoto Yamamoto (ORCID: https://orcid.org/0000-0003-0613-5451)
- Masaaki Murakawa (ORCID: https://orcid.org/0000-0001-6140-7953)
- Makoto Ueno (ORCID: https://orcid.org/0000-0003-4480-0029)
- Tatsuya Kanai
- Keisuke Kazama (ORCID: https://orcid.org/0000-0002-8155-8561)
- Aya Saito (ORCID: https://orcid.org/0000-0001-6731-2007)
- Rei Kanemoto
- Mariko Kamiya (ORCID: https://orcid.org/0000-0002-2867-423X)
- Naohiko Matsushita
Institutions
- Kanagawa Prefectural Hospital Organization (JP)
- Kanagawa Cancer Center
- Yokohama City University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.21873/anticanres.17804
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00